Guy looking at a ray of light

Connect. Heal. Thrive.

Ketamine Therapy

Ketamine-Assisted Therapy is now available for the treatment of depression, anxiety, PTSD and addiction disorders.

The power of psychedelic medicine combined with world-class therapeutic support.

Ketamine-assistedtherapy combines structured psychotherapy with the medical administration of ketamine. When used in controlled doses, ketamine is a psychoactive substance that can contribute to altered or ‘non-ordinary’ states of consciousness. Recent research has shown that, when combined with forms of counselling by trained mental health professionals, these psychedelic experiences can enable people to overcome a broad range of mental health challenges, ranging from depression and anxiety to addiction and trauma. 

Mountain view

The Process

It all starts with connection. The first step is to connect with our team of caring experts and make sure that the program is a good fit for you and your needs at this point in time. Psychedelic-assisted therapy isn’t for everyone, and your safety and wellbeing are our primary concern. We’ll work with you to determine whether you are eligible for treatment, and give you an opportunity to get to know the people who will be supporting you throughout your journey.

Once we’ve determined together that you’re eligible for treatment, we get working on setting you up for success. Psychedelic-assisted psychotherapy is a process. We’ll get to know you, and your story, and you’ll be provided with materials and training to ensure you get the most out of your sessions.

Your lived experience with the medicine is usually where things start to shift, and become more workable. These experiences can be blissful or challenging, mild or mind-blowing, depending on where you are in a treatment process and your unique story. Whatever the nature of your experience, you’ll receive the best possible care ensuring both physical and psychological safety.

An essential ingredient to ensuring that the potential of your psychedelic experience is properly and safely harnessed, integration may be the most important part of your healing journey. If a psychedelic experience is about breaking open all that is stuck and stagnant, integration is about putting the pieces back together in a new, more balanced configuration.

Healing isn’t a linear, individual process with a clear finish line. Sometimes we transform and peel back a layer only to reveal deeper more significant work that we now have the capacity to undertake. Reconnecting can mean pursuing additional treatment, joining one of our ongoing integration groups, or even taking what you’ve learned and lived and becoming a positive healing presence in someone else’s life.

What can ketamine-assisted therapy treat?

Depression

Available Now

Anxiety

Available Now

PTSD

Available Now

Addiction Disorder

Available Now

Eating Disorders

Under Development

Chronic Pain

Under Development

Our Ketamine Team

Begin Your Healing Journey

The first step is to book an intake call to discuss whether Ketamine-Assisted Therapy is a good fit for you. 

Let's Get Started
Woman with her eyes closed

Frequently Asked Questions

Ketamine is a synthetic pharmaceutical compound classified as a dissociative anesthetic. It is a widely used medication and is on the World Health Organization’s List of Essential Medicines. It was developed in 1963, approved for use in 1970, and adopted by many jurisdictions because of its rapid onset, proven safety, and short duration of action.

Ketamine is most commonly used as an anesthetic agent in surgical and emergency department settings due to its good safety profile. It has also been utilized successfully in managing acute and chronic pain conditions due to its analgesic properties.

While ketamine is known to be used recreationally as a street drug outside of medical applications, its use in this context is unrelated to medical and therapeutic use, which has been shown to be safe and associated with positive outcomes.

In the last two decades, ketamine has been increasingly clinically applied at subanesthetic doses as an off-label treatment for various chronic treatment-resistant mental health conditions, such as depression, substance use disorder, post-traumatic stress disorder, obsessive-compulsive disorder, and other mental health diagnoses. If you have any questions or concerns about ketamine itself, don’t hesitate to inquire with the Numinus medical team about it during the screening process.

Ketamine-assisted psychotherapy combines structured psychotherapy with the medical administration of ketamine. When used in controlled doses, ketamine is a psychoactive substance that can contribute to altered or ‘non-ordinary’ states of consciousness. Recent research has shown that, when combined with forms of counselling by trained mental health professionals, these psychedelic experiences can enable people to overcome a broad range of mental health challenges, ranging from depression and anxiety to addiction and trauma.

In the context of ketamine-assisted psychotherapy, the opportunity is to harness the openness of this altered state with structured psychotherapy to engage with and process strong emotions that may otherwise be painful or simply difficult to access. Cultivating this emotional awareness with your therapist can then make it possible to ‘reorganize’ core experiences, see important relationships in a new light, and create a coherent and meaningful narrative that supports positive transformation, and coming into balance.

Ketamine can be administered in a number of ways, including intravenous infusion (IV), intramuscular injection (IM), as well as via nasal sprays and lozenges or rapid dissolving tablets that are placed under the tongue. At Numinus, presently only nasal spray and rapid dissolving tablets are used for ketamine-assisted psychotherapy. The specific dose and method is determined on a case-by-case basis with your medical team at Numinus.

At the dosages provided at Numinus, while under the effect of ketamine, you will most likely experience mild reductions in pain, anxiety and depression, in addition to other possible psychoactive effects such as:

  • Increased sensitivity to light and sound
  • A dream-like or ‘floating’ feeling
  • Diminished body sensations
  • Altered sense of time
  • Mild changes in perception of sound and vision
  • Relaxation of ordinary concerns and usual mindset
  • Disruption of negative feelings and preoccupations

While many clients find the effects of ketamine to be pleasurable, ketamine-assisted psychotherapy can involve experiencing uncomfortable feelings, engaging in difficult interactions, revisiting painful experiences, or being challenged to see the world in new and different ways. Additional details of the therapeutic approach will be shared with you should you choose to go forward with ketamine-assisted psychotherapy.

During the ketamine dosing sessions, you will be in a room that has been specifically designed to support ketamine and other psychedelic-assisted psychotherapies, and to feel as comfortable as possible. Most clients will prefer to rest in a semi-reclined or reclined position. You will have the opportunity to wear eye-shades if desired, and listen to preselected music, specifically designed to enhance the experience, if desired.

Ketamine-assisted psychotherapy is only available to individuals over the age of 18 years old (Quebec) or 19 years old (British Columbia). At present, youth under 18 years of age, pregnant women and nursing mothers are not eligible for ketamine-assisted psychotherapy, since the effects of ketamine on pregnancy, nursing children and youth are still relatively unknown. Though research indicates that ketamine-assisted psychotherapy may be effective for a number of mental health indications, Numinus is currently focused on addressing treatment-resistant depression.

To be eligible for ketamine-assisted psychotherapy for depression, you must be evaluated by a medical practitioner and not have any contraindications to this therapy, including any medical or other psychiatric illnesses that suggest this treatment might be unsafe. Conditions that may make you ineligible for ketamine-assisted psychotherapy include, but are not limited to: a history of psychosis (e.g. hallucinations), mania, untreated hypertension, heart disease or stroke, and seizure. Similarly, severe liver disease, untreated thyroid disorders or other medical conditions may require management prior to ketamine-assisted psychotherapy.

If you are suffering from treatment-resistant depression our team will work directly with you to determine whether you are a good candidate for treatment by taking a full medical and psychological history.

Ketamine-assisted psychotherapy is an exciting innovation in mental health care, but because it is still new, it is presently still an uninsured medical service. Unless you have a private insurance provider or other provider to pay for ketamine-assisted psychotherapy, you will need to pay out of pocket as it is presently an uninsured service. However, if you have a private insurance provider you may be able to claim some or all of the individual psychotherapy sessions. We will provide you with a detailed breakdown of the costs for each aspect of the service should you require it for any additional insurance coverage you may have. Please contact us for additional pricing information.

At Numinus, your safety is our top priority. To help us meet that commitment, Numinus has put in place policies and protocols to protect our clients while they access our therapists and services.

Psychedelic-assisted therapy offers strong potential to help individuals struggling with issues like depression, anxiety, trauma and addiction. In research trials, compounds used in psychedelic-assisted psychotherapies – such as MDMA, psilocybin and ketamine – have been found to be safe from a human toxicology perspective and, while research is ongoing, may provide substantial improvement over available pharmacotherapies in terms of both safety and efficacy.

We recognize that there can be risks to patients while under the influence of psychedelic substances and potentially for days or weeks following administration, when close attention is not paid to the appropriateness of the clinical setting, the therapeutic protocols, or the calibre of attending therapist(s). Specifically, people undergoing psychedelic-assisted therapy may be vulnerable to manipulation and exploitation for a period before, during and after psychedelic experiences. Additionally, many people seeking psychedelic-assisted psychotherapy have unresolved trauma and are at risk of re-traumatization if accompanied by unskilled practitioners.

To mitigate risks, Numinus has implemented strict processes for the recruitment and training of highly skilled and professional therapists with expertise in trauma therapy. All Numinus therapists have passed criminal record checks in their local jurisdictions. In addition, they must comply with a Numinus Wellness Code of Ethics that prioritizes client care and safety.

Numinus’ protocols are based on international best safety practices, and our clinic infrastructure has been specifically developed for client safety. A range of safeguards are in place, including the filming of psychedelic sessions. Storage of the recording is secure and confidential and meets all medical regulatory standards.

All safety protocols are explained to clients as part of our admission procedures, and all our services are in compliance with local, provincial and federal health regulations.